Genentech/Roche Releases Clinical Trial Update for RG7916
Genentech/Roche recently provided the following community statement with clinical trial updates for SUNFISH (Type 2/3). The SUNFISH trial is advancing to part two, which is designed to be a pivotal, marketing registration trial. Dear SMA Community, We are focused on progressing our studies with our investigational molecule RG7916 with utmost speed and quality and are […]
Genentech/Roche Releases Clinical Trial Update for RG7916 Read More »